Takeda Pharmaceutical Company is a pharmaceuticals group focusing on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines.
Sectors
- News & Analysis
Takeda
Nov 17, 2023 • Robert Lavine
LEADERSHIP SOCIETY
Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.EventsGCV Institute: CVC Investment ProgramsOct 22 -
Oct 23, 2024
Palo Alto, CA (USA)EventsGCV Executive Leadership Forum 2024Oct 24, 2024
Menlo Park, CA (USA)EventsCorporate Venture in Brasil 2024 – International Delegation to BrazilOct 28 -
Oct 30, 2024
São Paulo (Brazil)EventsGCV Connect: Germany 2024Oct 29, 2024
Frankfurt (Germany)EventsGCV Institute: CVC Investment ProgramsOct 30 -
Oct 31, 2024
Frankfurt (Germany)EventsWebinar: Pop, beauty and chips - How to invest in South KoreaNov 7, 2024
OnlineEventsGCV Asia Congress & International Delegation 2024Nov 11 -
Nov 14, 2024
Tokyo (Japan)EventsGCV Connect: Miami 2024Nov 19, 2024
Miami, FL (USA)EventsGCV Connect: Korea 2024Dec 10 -
Dec 12, 2024
Seoul (South Korea)EventsGCVI Summit 2025Mar 18 -
Mar 20, 2025
Monterey, CA (USA)Top News
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
© 2024 Mawsonia Ltd. All rights reserved.test regLogin
